Cyclin D1 (CD1), interleukin-6 (IL-6), Ki67, transforming growth factor beta type II receptor, HER-2 and prediction of relapse in women with early stage breast cancer (BC) taking tamoxifen
Year: 2004
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: University of Vermont, Dartmouth–Hitchcock Medical Center
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2531581624
